Thorpe A C, Cleary R, Coles J, Vernon S, Reynolds J, Neal D E
Department of Urology, Freeman Hospital, Newcastle upon Tyne, UK.
Br J Urol. 1994 Nov;74(5):559-65. doi: 10.1111/j.1464-410x.1994.tb09184.x.
To determine the degree of variation in mortality and major morbidity following transurethral resection of the prostate (TURP), and to assess intersite variation for mortality and morbidity over 12 sites within the Northern Region. Further, to determine whether the previously observed effects on morbidity of unit size, patient through-put and emergency admission were borne out in contemporary urological practice in the Northern Region.
For an 8 month period, 1 April 1991-31 November 1991, an independent audit of TURP was performed on 12 different hospital sites throughout the Northern Region. A constant data set was designed which was collected on each patient before and 3 months after operation by two independent clinical co-ordinators who travelled to each of the sites. All case notes were reviewed at 3 months after operation by the co-ordinators using a standard proforma, rather than depending upon self reporting by medical staff. Data on factors potentially affecting mortality and morbidity were collected, including emergency admission, diagnosis of prostate cancer, American Society of Anesthesiologists' co-morbidity scores, and age and differences in throughput in the 12 sites. The effect of through-put or 'volume' on mortality and morbidity was assessed by comparing morbidity and the number of cases performed.
The early mean death rate was 13 of 1396 patients (0.9%), with an inter-site variation ranging from 0% to 3.8%. A mean of 2.0% of men were returned to theatre after TURP, 2.4% of patients received a blood transfusion (> 2 units) after operation, and 8.0% of patients developed post-operative sepsis; these complications varied sixfold, sevenfold and 17-fold across the different sites respectively. Those units performing < or = 100 operations over the audit period (equivalent to < 150 operation per year) had a significantly increased rate of deaths and complications which was not related to population differences, though some low volume units had good results. Elderly men who were admitted as emergencies or with prostate cancer were particularly vulnerable to complications.
The overall early mortality rate after TURP for benign prostatic hyperplasia across the Region compares well with other reported large series. The significant variation in morbidity rates found in this study suggests that careful attention needs to be paid by Urologists, Purchasers and Providers to morbidity rates after prostatectomy.
确定经尿道前列腺切除术(TURP)后死亡率和主要并发症的变化程度,并评估北部地区12个医疗点之间死亡率和并发症的差异。此外,确定之前观察到的单位规模、患者周转率和急诊入院对并发症的影响在北部地区当代泌尿外科实践中是否得到证实。
在1991年4月1日至1991年11月31日的8个月期间,对北部地区12个不同医院的医疗点进行了TURP独立审计。设计了一个固定的数据集,由两名独立的临床协调员在每个医疗点对每位患者术前及术后3个月进行收集。术后3个月,协调员使用标准表格对所有病例记录进行审查,而不是依赖医务人员的自我报告。收集了可能影响死亡率和并发症的因素的数据,包括急诊入院、前列腺癌诊断、美国麻醉医师协会的合并症评分、年龄以及12个医疗点的周转率差异。通过比较并发症发生率和手术例数,评估周转率或“手术量”对死亡率和并发症的影响。
1396例患者中早期平均死亡率为13例(0.9%),各医疗点之间的差异范围为0%至3.8%。平均2.0%的男性在TURP后返回手术室,2.4%的患者术后接受输血(超过2单位),8.0%的患者发生术后脓毒症;这些并发症在不同医疗点的差异分别为6倍、7倍和17倍。在审计期间进行手术≤100例(相当于每年<150例手术)的单位,其死亡率和并发症发生率显著增加,这与人口差异无关,尽管一些低手术量单位效果良好。因急诊入院或患有前列腺癌的老年男性特别容易发生并发症。
该地区良性前列腺增生症患者TURP后的总体早期死亡率与其他报道的大型系列研究结果相当。本研究中发现的并发症发生率的显著差异表明,泌尿外科医生、采购方和医疗服务提供方需要密切关注前列腺切除术后的并发症发生率。